No Data
No Data
No Data
No Data
No Data
Express News | Novartis innovates PNH oral monotherapy ipcopam hydrochloride capsules approved in China
Breakings14minutes ago
Novartis Pharms Corp Gets FDA New Drug Application Approval For VIJOICE
Novartis Pharms Corp Gets FDA New Drug Application Approval For VIJOICE
BenzingaApr 25 23:09
Analysts Have Conflicting Sentiments on These Healthcare Companies: Carl Zeiss Meditec (GB:0DHC), Siemens Healthineers AG (OtherSEMHF) and Novartis AG (Six Swiss: CH:NOVN)
TipRanksApr 25 17:10
BMO Capital Maintains Market Perform on Novartis, Raises Price Target to $116
BMO Capital analyst Etzer Darout maintains Novartis with a Market Perform and raises the price target from $114 to $116.
Analyst UpgradesApr 24 23:03
Novartis Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/24/2024 18.77% BMO Capital $114 → $116 Maintains Market Perform 02/23/2024 16.72% BMO Capital → $114 In
BenzingaApr 24 23:02
Company News for Apr 24, 2024
Yahoo FinanceApr 24 21:36
No Data
No Data